Will you use ovarian function suppression in lieu of chemotherapy in premenopausal patients with pN1 ER+ HER2- breast CA with OncoType RS <25?  

Knowing the differential effect seen with menopausal status in RxPONDER, would you avoid chemotherapy or still offer chemotherapy, given that only 15.9% of premenopausal patients in the endocrine therapy arm were given OFS?

Answer from: Medical Oncologist at Community Practice
Medical Oncologist at Genesee Cancer and Blood Disease
What is recommended? Which types of N1 disease?
Medical Oncologist at NYU Langone Medical Center
Agree with @Suleiman A. Massarweh; if she gets che...
Sign in or Register to read more